The Vanguard Group Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has released a public disclosure under Rule 8.3 of the Takeover Code regarding its position in Spire Healthcare Group plc. As of February 13, 2026, Vanguard reported an interest of 14,509,117 ordinary shares, representing 3.60% of Spire Healthcare's relevant securities.

This disclosure follows a series of transactions, including the purchase of 3,954 shares and the sale of 23,112 shares, both at a unit price of 2.05 GBP. No cash-settled or stock-settled derivative transactions were reported, nor were there any rights to subscribe for new securities disclosed.

Furthermore, there are no indemnity or other dealing arrangements, and no agreements related to options or derivatives exist, as per the statement. The disclosure is effective as of February 16, 2026, and is made to comply with regulatory requirements.